Beauty Health (SKIN) Set to Announce Earnings on Monday

Beauty Health (NASDAQ:SKIN) is scheduled to post its quarterly earnings results after the market closes on Monday, November 13th. Analysts expect Beauty Health to post earnings of $0.03 per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings data on Wednesday, August 9th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The business had revenue of $117.50 million during the quarter, compared to the consensus estimate of $114.89 million. Beauty Health had a negative return on equity of 3.84% and a negative net margin of 3.83%. The business’s quarterly revenue was up 13.5% on a year-over-year basis. During the same period last year, the firm earned ($0.09) EPS. On average, analysts expect Beauty Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beauty Health Trading Down 3.2 %

SKIN opened at $3.60 on Friday. The company has a current ratio of 9.28, a quick ratio of 7.98 and a debt-to-equity ratio of 4.55. The firm has a market cap of $478.40 million, a price-to-earnings ratio of -25.71 and a beta of 1.24. Beauty Health has a 12 month low of $3.45 and a 12 month high of $13.90. The stock has a fifty day moving average price of $5.32 and a 200-day moving average price of $7.41.

Insiders Place Their Bets

In other Beauty Health news, CFO Michael P. Monahan purchased 5,000 shares of Beauty Health stock in a transaction that occurred on Thursday, August 17th. The stock was bought at an average price of $6.02 per share, with a total value of $30,100.00. Following the acquisition, the chief financial officer now owns 358,107 shares of the company’s stock, valued at approximately $2,155,804.14. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Chairman Brent L. Saunders purchased 59,380 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The shares were purchased at an average cost of $6.10 per share, with a total value of $362,218.00. Following the purchase, the chairman now owns 5,827,453 shares of the company’s stock, valued at approximately $35,547,463.30. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Michael P. Monahan bought 5,000 shares of Beauty Health stock in a transaction on Thursday, August 17th. The shares were purchased at an average cost of $6.02 per share, with a total value of $30,100.00. Following the acquisition, the chief financial officer now directly owns 358,107 shares of the company’s stock, valued at $2,155,804.14. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 97,380 shares of company stock worth $593,948. Company insiders own 41.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Virginia Retirement Systems ET AL purchased a new position in shares of Beauty Health in the second quarter worth about $238,000. Alliancebernstein L.P. grew its holdings in Beauty Health by 62.6% in the 2nd quarter. Alliancebernstein L.P. now owns 389,500 shares of the company’s stock valued at $3,260,000 after buying an additional 150,000 shares in the last quarter. Blueshift Asset Management LLC raised its holdings in shares of Beauty Health by 79.8% during the 2nd quarter. Blueshift Asset Management LLC now owns 30,156 shares of the company’s stock worth $252,000 after acquiring an additional 13,382 shares during the period. Stifel Financial Corp boosted its position in shares of Beauty Health by 16.1% during the 2nd quarter. Stifel Financial Corp now owns 238,376 shares of the company’s stock valued at $1,995,000 after acquiring an additional 33,014 shares during the last quarter. Finally, State of Wyoming grew its holdings in shares of Beauty Health by 83.6% in the second quarter. State of Wyoming now owns 15,456 shares of the company’s stock valued at $129,000 after purchasing an additional 7,037 shares during the period.

Wall Street Analyst Weigh In

Several brokerages have weighed in on SKIN. TD Cowen lowered their target price on shares of Beauty Health from $15.00 to $9.00 and set an “outperform” rating for the company in a research note on Thursday, August 10th. Benchmark reissued a “buy” rating and set a $23.00 target price on shares of Beauty Health in a research report on Wednesday, September 13th. DA Davidson dropped their price objective on shares of Beauty Health from $35.00 to $16.50 and set a “buy” rating on the stock in a report on Thursday, August 10th. Imperial Capital started coverage on Beauty Health in a research report on Tuesday, September 19th. They set an “outperform” rating for the company. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $10.00 price objective on shares of Beauty Health in a report on Friday, August 25th. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $14.69.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health.